Skip to content

Clinical trials

Active, not recruiting Ovarian Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Active, not recruiting Country / region: Germany Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20151
20162
20171
20181
20192
20202
20214
20222
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Hoffmann-La Roche2
Tesaro, Inc.2
AGO Study Group1
ARCAGY/ GINECO GROUP1
AbbVie1
BioNTech Cell & Gene Therapies GmbH1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Exelixis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms20
Carcinoma, Non-Small-Cell Lung6
Carcinoma, Renal Cell4
Colorectal Neoplasms4
Fallopian Tube Neoplasms4
Neoplasms4
Endometrial Neoplasms3
Head and Neck Neoplasms3
Breast Neoplasms2
Carcinoma, Ovarian Epithelial2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.